Fig 1.
Quality assessment based on PEDro scale of clinical controlled trials included in the network meta-analysis.
Note: PEDro = Physiotherapy Evidence Database.
Table 1.
Pairwise meta-analysis in terms of six endpoints.
Fig 2.
Network evidence plots of estimated blood loss (ml), operative time (min), number of pelvic lymph nodes removed, intraoperative complications, hospital stay (days) and postoperative complications of RRH, LRH and ORH in the treatment of early-stage CC.
Note: RRH, robotic radical hysterectomy; LRH, laparoscopic radical hysterectomy; ORH, open radical hysterectomy; CC cervical cancer.
Fig 3.
Relative relationship forest plots of estimated blood loss (ml), hospital stay (days) and postoperative complications of RRH, LRH and ORH in the treatment of early-stage CC.
Note: A = RRH (robotic radical hysterectomy); B = LRH (laparoscopic radical hysterectomy); C = ORH (open radical hysterectomy).
Table 2.
Weighted mean difference or odds ratio (95% confidence intervals) of three treatment modalities of six endpoint outcomes.
Table 3.
WMD/OR values and P values of direct and indirect pairwise comparisons of three treatment modalities under six endpoint outcomes.
Table 4.
SUCRA values of three treatment modalities under six endpoint outcomes.
Fig 4.
Cluster analysis diagram of estimated blood loss (ml), hospital stay (days) and postoperative complications of RRH, LRH and ORH in the treatment of early-stage CC.
Note: A = RRH (robotic radical hysterectomy); B = LRH (laparoscopic radical hysterectomy); C = ORH (open radical hysterectomy).
Fig 5.
Funnel plot of estimated blood loss (ml), operative time (min), number of pelvic lymph nodes removed, intraoperative complications, hospital stay (days) and postoperative complications of RRH, LRH and ORH in the treatment of early-stage CC.
Note: A = RRH (robotic radical hysterectomy); B = LRH (laparoscopic radical hysterectomy); C = ORH (open radical hysterectomy).